Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Response to the Letter to the Editor by Eshghi P et al.
Faranoush M, Shams M, Managhchi MR, Rezvani MR, Abolghasemi H, Iacobelli M. Faranoush M, et al. Among authors: managhchi mr. Haemophilia. 2020 Jul;26(4):e220. doi: 10.1111/hae.14020. Epub 2020 May 22. Haemophilia. 2020. PMID: 32441834 No abstract available.
A comparison between recombinant activated factor VII (Aryoseven) and Novoseven in patients with congenital factor VII deficiency.
Faranoush M, Abolghasemi H, Toogeh G, Karimi M, Eshghi P, Managhchi M, Hoorfar H, Dehdezi BK, Mehrvar A, Khoeiny B, Kamyar K, Heshmat R, Baghaeipour MR, Mirbehbahani NB, Fayazfar R, Ahmadinejad M, Naderi M. Faranoush M, et al. Among authors: managhchi m. Clin Appl Thromb Hemost. 2015 Nov;21(8):724-8. doi: 10.1177/1076029614522545. Epub 2014 Mar 19. Clin Appl Thromb Hemost. 2015. PMID: 24651301 Free article. Clinical Trial.
A Comparison of Efficacy Between Recombinant Activated Factor VII (Aryoseven) and Novoseven in Patients With Hereditary FVIII Deficiency With Inhibitor.
Faranoush M, Abolghasemi H, Mahboudi F, Toogeh G, Karimi M, Eshghi P, Managhchi M, Hoorfar H, Dehdezi BK, Mehrvar A, Khoeiny B, Vaziri B, Kamyar K, Heshmat R, Baghaeipour MR, Mirbehbahani NB, Fayazfar R, Ahmadinejad M, Naderi M. Faranoush M, et al. Among authors: managhchi m. Clin Appl Thromb Hemost. 2016 Mar;22(2):184-90. doi: 10.1177/1076029614555902. Epub 2014 Oct 24. Clin Appl Thromb Hemost. 2016. PMID: 25343955 Free article. Clinical Trial.
Cost-Effectiveness Analysis of Biogeneric Recombinant Activated Factor VII (AryoSeven™) and Activated Prothrombin Complex Concentrates (FEIBA™) to Treat Hemophilia A Patients with Inhibitors in Iran.
Golestani M, Eshghi P, Rasekh HR, Cheraghali AM, Salamzadeh J, Naderi M, Managhchi MR, Hoorfar H, Toogeh GR, Imani A, Khodayari MT, Habibpanah B, Hantooshzadeh R. Golestani M, et al. Among authors: managhchi mr. Iran J Pharm Res. 2016 Spring;15(2):669-77. Iran J Pharm Res. 2016. PMID: 27642341 Free PMC article.
Bone mineral density in hemophilia patients.
Roushan N, Meysamie A, Managhchi M, Esmaili J, Dormohammadi T. Roushan N, et al. Indian J Hematol Blood Transfus. 2014 Dec;30(4):351-5. doi: 10.1007/s12288-013-0318-4. Epub 2014 Jan 22. Indian J Hematol Blood Transfus. 2014. PMID: 25435741 Free PMC article.